Research

Stay ahead in the investement world with the latest stock insights from our internal research team.

January 15, 2026

Cybin Inc. (Helus Pharma) (HELP) Deep Research Report: Overvalued vs. Opportunity in Psychedelic Biotech for 2026–2027

Deep dive on Cybin/Helus (HELP): CYB003, CYB004, cash burn, dilution risk, and what the 2026 data calendar means for risk‑reward at today’s price.

DeepValue Research TeamRead article →

January 15, 2026

Enveric Biosciences (ENVB) Deep Research Report: High-Risk Micro-Cap or Optionality Play for 2026?

Deep dive on Enveric Biosciences: cash runway, Nasdaq risk, EB-003 pipeline, dilution math, and what has to go right before 2026 for equity to work.

DeepValue Research TeamRead article →

January 14, 2026

GH Research PLC (GHRS) Deep Research Report: High-Risk Upside or Fully Priced Psychedelic Bet in 2026?

GH Research is racing toward Phase 3 with a cash-rich balance sheet and hyped TRD data. We break down if the current stock price still offers upside.

DeepValue Research TeamRead article →

January 14, 2026

Mind Medicine (MindMed) Inc. (MNMD) Deep Research Report: High-Hype Psychedelic Bet or Smart Trim Before 2026 Data?

MindMed’s MM120 could reshape anxiety treatment, but the stock already prices in success. We break down 2026 catalysts, dilution risk, and valuation.

DeepValue Research TeamRead article →

January 13, 2026

Compass Pathways plc (CMPS) Deep Research Report: Binary Psychedelic Bet or Prudent Patience for 2026–2027?

Compass Pathways has positive Phase 3 data, big upside talk, and high risk. See what 2026–2027 catalysts mean for CMPS stock and where value investors should wait.

DeepValue Research TeamRead article →

January 13, 2026

High Tide Inc. (HITI) Deep Research Report: Discount-Club Moat, German Expansion, And What 2026 Investors Should Watch

High Tide’s discount-club model is gaining share and cash flow, but leverage and German regulation add risk. See if the risk/reward still skews bullish.

DeepValue Research TeamRead article →

January 12, 2026

Tempus AI, Inc. (TEM) Deep Research Report: Lofty Growth Expectations Meet Execution Risk in 2026

Tempus AI stock bakes in aggressive growth and margin gains. We break down the upside, downside, and what 2026 investors should watch now.

DeepValue Research TeamRead article →

January 12, 2026

Kaspi.kz (KSPI) Deep Research Report: Undervalued Super-App Facing Turkish Growing Pains in 2026

Kaspi.kz trades at a single-digit P/E despite 40%+ ROE. We break down Kazakhstan strength, Turkey risk, new taxes, and what that means for 2026 returns.

DeepValue Research TeamRead article →

January 11, 2026

DocuSign (DOCU) Deep Research Report: Can A High-Margin “Utility” Turn Into A Double-Digit Grower Again by 2027?

Deep dive on DocuSign’s 2026–2027 outlook: IAM adoption, ARR guidance, risks from Adobe/Microsoft, and whether current valuation still offers upside.

DeepValue Research TeamRead article →

January 11, 2026

Danaher Corporation (DHR) Deep Research Report: Priced for a 2026 Rebound – Or Time to Lock In Gains?

Danaher trades at a rich multiple on a tools rebound story. We break down growth, margins, risks and valuation to see if DHR is a buy or a trim.

DeepValue Research TeamRead article →

January 9, 2026

Constellation Brands (STZ) Deep Research Report: Margin Pressured or Opportunity in 2026? What Long-Term Investors Should Watch

Constellation Brands’ stock is down sharply, but beer margins stay rich. We break down volumes, tariffs, capex, and what must go right for upside.

DeepValue Research TeamRead article →

January 9, 2026

Sprouts Farmers Market (SFM) Deep Research Report: Oversold Opportunity or Value Trap After the 40% Drawdown?

Sprouts Farmers Market stock is down over 40%. We break down comps, margins, litigation risk and valuation to see if the selloff is a buying chance.

DeepValue Research TeamRead article →

January 8, 2026

SBC Medical Group Holdings Inc. (SBC) Deep Research Report: Restructuring Pop or Durable Cash Machine by 2027?

SBC Medical looks cheap and cash-rich, but earnings quality, related-party risk, and cash flow make this a stock where patience may beat urgency.

DeepValue Research TeamRead article →

January 8, 2026

China Automotive Systems (CAAS) Deep Research Report: Deep Value, High Risk – Can This Auto Supplier Reward Patient Investors by 2027?

Deep dive on China Automotive Systems: valuation, growth drivers, risks, and scenarios for CAAS stock. Is this underfollowed auto supplier a value trap or opportunity?

DeepValue Research TeamRead article →

January 7, 2026

Greenland Technologies Holding Corp. (GTEC) Deep Research Report: Deep Value or Value Trap for 2026 Micro-Cap Investors?

GTEC trades near liquidation-style multiples despite positive cash flow and 30% gross margins. We break down the real risks, upside, and what to watch.

DeepValue Research TeamRead article →

January 7, 2026

Transportadora de Gas del Sur S.A. (TGS) Deep Research Report: Waiting for Proof or a Better Price in a High-Risk, High-Reward Market

Deep dive on TGS ADRs: valuation, tariffs, Vaca Muerta growth and Argentina risk. Why we rate it a wait and what must go right before buying.

DeepValue Research TeamRead article →

January 6, 2026

Tilray Brands (TLRY) Deep Research Report: Crowded Policy Trade Or Patient Value Play by 2028?

Tilray trades below book with reset assets and crowded cannabis hype. We break down impairments, dilution, and what must improve before it's a buy.

DeepValue Research TeamRead article →

January 6, 2026

POET Technologies Inc. (POET) Deep Research Report: Speculative AI Photonics Play With More Hype Than Proof?

POET trades near a $1B valuation on minimal revenue and heavy losses. We break down the AI optics story, dilution risk, and what must go right.

DeepValue Research TeamRead article →

January 5, 2026

Okta, Inc. (OKTA) Deep Research Report: Overvalued vs. Opportunity in Identity-First Security?

Deep dive on Okta’s profitability pivot, competitive risks, security overhang, and valuation to see whether the stock still offers attractive long-term upside.

DeepValue Research TeamRead article →

January 5, 2026

Cloudflare (NET) Deep Research Report: Priced for Perfection or Just Getting Started?

Cloudflare is growing fast with rising free cash flow—but is the stock’s lofty valuation justified, or are investors underwriting a perfection story?

DeepValue Research TeamRead article →

January 4, 2026

Halliburton (HAL) Deep Research Report: Cyclical Upside, Cash Returns, and What Could Break the Thesis

Halliburton trades below our intrinsic value estimate but faces a clear cyclical downshift. We break down risks, cash flows, and upside for patient investors.

DeepValue Research TeamRead article →

January 4, 2026

TechnipFMC (FTI) Deep Research Report: Quality Cyclical or Fully Priced Risk Play for Offshore Investors?

Deep dive on TechnipFMC’s subsea turnaround, backlog strength, and valuation risk. Is this quality cyclical still attractive after a 63% run‑up?

DeepValue Research TeamRead article →

January 2, 2026

Moody's Corporation (MCO) Deep Research Report: Richly Priced Oligopoly or Risky Bet on Perpetual Growth?

Moody’s combines an elite ratings oligopoly with fast-growing analytics, but its lofty valuation leaves little margin of safety for value investors.

DeepValue Research TeamRead article →

January 2, 2026

Republic Services (RSG) Deep Research Report: High-Quality Cash Flows, Thin Margin of Safety for 2026 Buyers

Republic Services offers resilient cash flows and ESG tailwinds, but rich valuation and environmental risks leave limited margin of safety for new investors.

DeepValue Research TeamRead article →

January 1, 2026

UiPath (PATH) Deep Research Report: Premium Valuation, Slowing ARR – Is the Risk‑Reward Still Attractive?

UiPath pairs high margins and cash with slowing ARR and rich valuation. We break down if the automation leader’s stock still offers upside.

DeepValue Research TeamRead article →

January 1, 2026

Concentrix (CNXC) Deep Research Report: Deep Value, High Leverage – Is the Risk/Reward Worth It in 2026?

Concentrix trades at deep-value multiples with strong FCF but elevated leverage and AI risk. We break down whether the risk/reward now favors patient investors.

DeepValue Research TeamRead article →

December 31, 2025

Oceaneering International (OII) Deep Research Report: Cyclical Upside or Value Trap at Today’s Premium Valuation?

Deep dive on Oceaneering’s earnings momentum, backlog strength, free cash flow volatility, and valuation risk for value-focused investors.

DeepValue Research TeamRead article →

December 31, 2025

Baker Hughes (BKR) Deep Research Report: Overvalued vs. Opportunity: What Investors Should Watch Next

Baker Hughes blends LNG growth and solid cash flow with cyclical risk and rich valuation. See if the risk/reward justifies trimming or holding.

DeepValue Research TeamRead article →

December 30, 2025

Bristow Group (VTOL) Deep Research Report: Cyclical Upside or Value Trap for 2026-Oriented Investors?

Deep dive on Bristow Group’s improving earnings, offshore cycle leverage, SAR contracts, and balance sheet risk to see if VTOL offers real value.

DeepValue Research TeamRead article →

December 30, 2025

Helix Energy Solutions Group (HLX) Deep Research Report: Deep Cyclical Upside or Value Trap at 0.6x Book?

Helix trades at a steep discount to book and DCF while delivering its best free cash flow in decades. We unpack the upside, risks, and key 2025–26 watchpoints.

DeepValue Research TeamRead article →

December 29, 2025

Constellation Energy (CEG) Deep Research Report: Bull vs. Bear Case for 2026 Investors Weighing Nuclear, AI and Policy Risk

Constellation’s nuclear scale, AI power demand and Calpine deal create upside—but rich valuation and volatile cash flows limit margin of safety.

DeepValue Research TeamRead article →

December 29, 2025

Vistra Corp. (VST) Deep Research Report: Priced for Perfection in 2026 – Or Is It Time to Trim?

Deep dive on Vistra (VST): cash flow strength, nuclear/IRA tailwinds, policy and leverage risks, and why our team sees limited upside at today’s price.

DeepValue Research TeamRead article →

December 25, 2025

Range Resources (RRC) Deep Research Report: Overvalued or a Gas-Levered Opportunity for 2026 Investors?

Our deep dive into Range Resources (RRC) shows a quality, low-cost gas producer trading at rich multiples with limited margin of safety at current prices.

DeepValue Research TeamRead article →

December 24, 2025

Viper Energy (VNOM) Deep Research Report: A Smart Income Play or a Governance Risk in 2026?

Deep dive on Viper Energy (VNOM): Permian royalty model, cash flows, leverage, Sitio deal, and whether the stock looks attractive for long-term income investors.

DeepValue Research TeamRead article →

December 23, 2025

Diamondback Energy (FANG) Deep Research Report: A Buy for Permian Exposure and Free Cash Flow in 2026?

Deep dive on Diamondback Energy’s Permian scale, free cash flow, leverage, and 2026 impairment risk to see if FANG stock is attractive now.

DeepValue Research TeamRead article →

December 22, 2025

Texas Pacific Land Corporation (TPL) Deep Research Report: Too Expensive After the AI Boom?

Texas Pacific Land combines elite Permian royalties with AI and water upside—but a rich valuation leaves little margin of safety for value investors.

DeepValue Research TeamRead article →

December 21, 2025

Power Solutions International (PSIX) Deep Research Report: Overvalued After a 258% Run?

Power Solutions International’s turnaround is real, but is PSIX stock priced for perfection? We break down growth, risks, valuation, and 2025–2027 outlook.

DeepValue Research TeamRead article →

December 20, 2025

NRG Energy (NRG) Deep Research Report: Priced For Perfection Or Still Worth Holding In 2026?

NRG is riding the data-center power boom, but high leverage and rich valuation limit margin of safety. We break down risks, cash flows, and what investors should watch.

DeepValue Research TeamRead article →

December 19, 2025

EQT Corporation (EQT) Deep Research Report: Worth the Premium After Its Midstream Merger and LNG Pivot?

Deep dive on EQT stock: integrated gas plus midstream, LNG upside, debt reduction, and why today’s premium valuation leaves a slim margin of safety.

DeepValue Research TeamRead article →

December 18, 2025

Chevron Corporation (CVX) Deep Research Report: Still Worth Holding at a Premium in 2026?

Chevron offers quality assets, strong cash flow, and a rising dividend—but trades ~32% above DCF. We break down whether CVX is still worth holding.

DeepValue Research TeamRead article →

December 17, 2025

Textron Inc. (TXT) Deep Research Report: Is it Priced for Perfection in 2026 – Or Is It Time to Trim?

Textron mixes strong aviation and defense assets with solid cash flow—but TXT stock trades rich to FCF. We break down risks, catalysts, and valuation.

DeepValue Research TeamRead article →

December 16, 2025

International Seaways (INSW) Research Report: A Cyclical Value Opportunity For 2025–2027 Investors?

International Seaways (INSW) offers leveraged tanker exposure, strong cash returns, and a de-risked balance sheet. Is the stock undervalued today?

DeepValue Research TeamRead article →

December 15, 2025

Antero Midstream Corporation (AM) Stock Analysis: Still a Buy After Its 20% Run, or Just an Income Hold for 2026?

Deep dive on Antero Midstream (AM): dividend safety, cash flows, risks, valuation, and what investors should watch before buying after a 20% rally.

DeepValue Research TeamRead article →

December 14, 2025

Antero Resources (AR) Stock Analysis: Is Antero Resources Worth the Risk for Natural Gas Bulls in 2025–2026?

Deep dive on Antero Resources stock: gas/NGL leverage, HG Energy deal, deleveraging targets, valuation, risks, and what investors should watch next.

DeepValue Research TeamRead article →

December 13, 2025

Aemetis, Inc. (AMTX) Stock Analysis: Is Aemetis a Deep Value Play or a Value Trap in 2025?

Deep dive on Aemetis (AMTX): balance sheet stress, going‑concern risk, RNG and SAF upside, and what today’s valuation really implies for investors.

DeepValue Research TeamRead article →

December 12, 2025

NextDecade Corporation (NEXT) Stock Analysis: Is NEXT a Binary Bet or a 10-Year LNG Winner?

Deep research on NextDecade (NEXT): Rio Grande LNG status, FERC/DOE risk, leverage, and what needs to go right for long-term investors.

DeepValue Research TeamRead article →

December 11, 2025

Ameren Corporation (AEE) Stock Analysis: Is Ameren A Fairly Valued Utility Or A Buy-On-Dip Opportunity For 2025?

Deep dive on Ameren (AEE): regulated monopoly, 10% rate-base growth, heavy capex, equity dilution, and regulatory/ESG risks for long-term investors.

DeepValue Research TeamRead article →

December 10, 2025

SM Energy (SM) Stock Analysis: Deep Dive on Valuation, Cash Flow, and the Civitas Merger

SM Energy (SM) trades at low multiples despite strong cash flow and reserves. We break down valuation, risks, Uinta, and the pending Civitas merger.

DeepValue Research TeamRead article →

December 9, 2025

Crescent Energy (CRGY) Stock Analysis: Leverage, Reserves, and Roll-Up Risk

Deep research of Crescent Energy (CRGY) stock: reserves vs. leverage, KKR governance, Vital deal risk, and FCF for value-focused investors.

DeepValue Research TeamRead article →

December 8, 2025

ExxonMobil (XOM) Stock Analysis: Cash Flows, Capex, and Energy Transition Risk

Our deep research on ExxonMobil (XOM) stock reviews cash flow strength, capex plans, energy transition risks, and upside potential for long-term investors.

DeepValue Research TeamRead article →

December 7, 2025

Occidental Petroleum (OXY) Stock Analysis: Deleveraging, Permian Growth & CCUS Optionality

Our deep research on Occidental Petroleum (OXY) reviews Permian growth, deleveraging, the OxyChem sale, CCUS/DAC upside and key risks for long-term investors.

DeepValue Research TeamRead article →

December 6, 2025

Matador Resources (MTDR) Stock Analysis: Delaware Basin Growth, Midstream Moat & Valuation Deep Dive

Our MTDR stock deep research reviews Delaware Basin growth, midstream assets, free cash flow, risks and valuation to see if Matador is a buy.

DeepValue Research TeamRead article →

December 5, 2025

Vital Energy (VTLE) Stock Analysis: Event-Driven Deep Research on a Leveraged Permian Producer

Vital Energy (VTLE) is being acquired by Crescent Energy. We unpack its leverage, cash flows, Permian assets, and deal-driven setup for investors.

DeepValue Research TeamRead article →

December 4, 2025

Canadian Natural Resources Stock Analysis (CNQ): Deep Dive on Valuation, FCF, and Policy Risk

In-depth CNQ stock research: valuation, free cash flow strength, oil sands moat, and climate-policy risks for long-term investors.

DeepValue Research TeamRead article →

December 3, 2025

Enterprise Products Partners (EPD) Stock Analysis: Distribution Strength, Leverage, and Long-Term Midstream Moat

Enterprise Products Partners (EPD) stock deep research on distribution safety, leverage, growth projects, and risks for long-term income investors in 2025.

DeepValue Research TeamRead article →

December 2, 2025

Williams Companies (WMB) Stock Analysis: Lofty Valuation vs. Cash Flow Reality

Deep research on Williams (WMB) stock: valuation, leverage, cash flows, and risk factors for income and value investors assessing this midstream leader.

DeepValue Research TeamRead article →

December 1, 2025

BigBear.ai (BBAI) Stock Analysis: Why This AI Defense Play Looks Overpriced After a Huge Run

Deep research on BigBear.ai (BBAI) stock, its AI defense story, revenue outlook, capital structure, and risks after a ~199% 12‑month rally.

DeepValue Research TeamRead article →

November 30, 2025

Copart (CPRT) Stock Analysis: Margin Strength, FCF Growth, and a 2025 Value Opportunity

Copart (CPRT) stock deep research: high margins, strong free cash flow, net cash balance sheet, and a 26% DCF discount. Is this pullback a buying chance?

DeepValue Research TeamRead article →

November 29, 2025

CleanSpark (CLSK) Stock Analysis: Bitcoin Mining Leverage with AI/HPC Optionality

Deep dive on CleanSpark (CLSK) stock: Bitcoin‑levered miner with modern fleet, light leverage, negative FCF, and AI/HPC upside. Is the risk/reward worth it?

DeepValue Research TeamRead article →

November 28, 2025

TeraWulf (WULF) Stock Analysis: AI, Bitcoin, and a Stretched Valuation?

Detailed TeraWulf (WULF) stock deep research covering AI/HPC strategy, bitcoin exposure, leverage, dilution risk, and what investors should watch next.

DeepValue Research TeamRead article →

November 27, 2025

Arq Inc. (ARQ) Stock Analysis: Deep Research on a High-Risk Environmental Play

Arq (ARQ) looks optically cheap, but GAC ramp issues, thin liquidity, and execution risk dominate the story. See if the risk/reward fits your strategy.

DeepValue Research TeamRead article →

November 26, 2025

Joby Aviation (JOBY) Stock Analysis: High-Risk eVTOL Leader With Long-Dated Upside

Deep research on Joby Aviation (JOBY) stock: cash runway, FAA certification timing, revenue trends, and risk/reward for eVTOL investors.

DeepValue Research TeamRead article →

November 25, 2025

Harrow Health (HROW) Stock Analysis: High-Growth Ophthalmology Play With Stretched Balance Sheet

Deep research on Harrow Health (HROW) stock: growth, margins, leverage, and regulatory risk in its ophthalmic portfolio. Is the risk/reward still attractive?

DeepValue Research TeamRead article →